BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 8985359)

  • 1. The vesicular stomatitis virus matrix protein inhibits transcription from the human beta interferon promoter.
    Ferran MC; Lucas-Lenard JM
    J Virol; 1997 Jan; 71(1):371-7. PubMed ID: 8985359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ability of the matrix protein of vesicular stomatitis virus to suppress beta interferon gene expression is genetically correlated with the inhibition of host RNA and protein synthesis.
    Ahmed M; McKenzie MO; Puckett S; Hojnacki M; Poliquin L; Lyles DS
    J Virol; 2003 Apr; 77(8):4646-57. PubMed ID: 12663771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inducible and conditional inhibition of human immunodeficiency virus proviral expression by vesicular stomatitis virus matrix protein.
    Paik SY; Banerjea AC; Harmison GG; Chen CJ; Schubert M
    J Virol; 1995 Jun; 69(6):3529-37. PubMed ID: 7745700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potency of wild-type and temperature-sensitive vesicular stomatitis virus matrix protein in the inhibition of host-directed gene expression.
    Lyles DS; McKenzie MO; Ahmed M; Woolwine SC
    Virology; 1996 Nov; 225(1):172-80. PubMed ID: 8918544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Homotypic and heterotypic exclusion of vesicular stomatitis virus replication by high levels of recombinant polymerase protein L.
    Meier E; Harmison GG; Schubert M
    J Virol; 1987 Oct; 61(10):3133-42. PubMed ID: 3041035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polyadenylation of vesicular stomatitis virus mRNA dictates efficient transcription termination at the intercistronic gene junctions.
    Hwang LN; Englund N; Pattnaik AK
    J Virol; 1998 Mar; 72(3):1805-13. PubMed ID: 9499031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Full-length genome analysis of natural isolates of vesicular stomatitis virus (Indiana 1 serotype) from North, Central and South America.
    Rodriguez LL; Pauszek SJ; Bunch TA; Schumann KR
    J Gen Virol; 2002 Oct; 83(Pt 10):2475-2483. PubMed ID: 12237430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contrasting effects of matrix protein on apoptosis in HeLa and BHK cells infected with vesicular stomatitis virus are due to inhibition of host gene expression.
    Kopecky SA; Lyles DS
    J Virol; 2003 Apr; 77(8):4658-69. PubMed ID: 12663772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The VSV matrix protein inhibits NF-κB and the interferon response independently in mouse L929 cells.
    Marquis KA; Becker RL; Weiss AN; Morris MC; Ferran MC
    Virology; 2020 Sep; 548():117-123. PubMed ID: 32838932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of vesicular stomatitis virus matrix protein in inhibition of host-directed gene expression is genetically separable from its function in virus assembly.
    Black BL; Rhodes RB; McKenzie M; Lyles DS
    J Virol; 1993 Aug; 67(8):4814-21. PubMed ID: 8392615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fusion-active glycoprotein G mediates the cytotoxicity of vesicular stomatitis virus M mutants lacking host shut-off activity.
    Hoffmann M; Wu YJ; Gerber M; Berger-Rentsch M; Heimrich B; Schwemmle M; Zimmer G
    J Gen Virol; 2010 Nov; 91(Pt 11):2782-93. PubMed ID: 20631091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a consensus mutation in M protein of vesicular stomatitis virus from persistently infected cells that affects inhibition of host-directed gene expression.
    Ahmed M; Lyles DS
    Virology; 1997 Oct; 237(2):378-88. PubMed ID: 9356348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Matrix protein of VSV New Jersey serotype containing methionine to arginine substitutions at positions 48 and 51 allows near-normal host cell gene expression.
    Kim GN; Kang CY
    Virology; 2007 Jan; 357(1):41-53. PubMed ID: 16962155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vesicular stomatitis viruses resistant to the methylase inhibitor sinefungin upregulate RNA synthesis and reveal mutations that affect mRNA cap methylation.
    Li J; Chorba JS; Whelan SP
    J Virol; 2007 Apr; 81(8):4104-15. PubMed ID: 17301155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assembly functions of vesicular stomatitis virus matrix protein are not disrupted by mutations at major sites of phosphorylation.
    Kaptur PE; McKenzie MO; Wertz GW; Lyles DS
    Virology; 1995 Feb; 206(2):894-903. PubMed ID: 7856102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of vesicular stomatitis virus matrix protein on transcription directed by host RNA polymerases I, II, and III.
    Ahmed M; Lyles DS
    J Virol; 1998 Oct; 72(10):8413-9. PubMed ID: 9733895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NF-kappaB activation Is delayed in mouse L929 cells infected with interferon suppressing, but not inducing, vesicular stomatitis virus strains.
    Boulares AH; Ferran MC; Lucas-Lenard J
    Virology; 1996 Apr; 218(1):71-80. PubMed ID: 8615043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutational analyses of the intergenic dinucleotide and the transcriptional start sequence of vesicular stomatitis virus (VSV) define sequences required for efficient termination and initiation of VSV transcripts.
    Stillman EA; Whitt MA
    J Virol; 1997 Mar; 71(3):2127-37. PubMed ID: 9032346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of vesicular stomatitis virus matrix protein on host-directed translation in vivo.
    Black BL; Brewer G; Lyles DS
    J Virol; 1994 Jan; 68(1):555-60. PubMed ID: 8254771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complementary Mutations in the N and L Proteins for Restoration of Viral RNA Synthesis.
    Li W; Gumpper RH; Uddin Y; Schmidt-Krey I; Luo M
    J Virol; 2018 Nov; 92(22):. PubMed ID: 30135126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.